Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
100%
Gamma Interferon
100%
Injury
57%
Infection
57%
Mouse
57%
Disease
28%
Blast Injury
28%
Lung Injury
28%
Inflammation
14%
Mouse Strain
14%
Tissue Injury
14%
Arthropathy
14%
Lung Infection
14%
Bacterial Pneumonia
14%
Lung Fibrosis
14%
Pneumonia
14%
Chronic Obstructive Lung Disease
14%
Adult Respiratory Distress Syndrome
14%
Keyphrases
Interferon-γ
50%
Acute Lung Injury
50%
CRISPR Interference (CRISPRi)
50%
Neutrophils
50%
Lung Damage
20%
Burn pits
15%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
10%
Lung Injury
10%
Trauma Injuries
10%
Palindromic Repeat
10%
Blast Injury
10%
Etiology
5%
White Blood Cells
5%
Ongoing Development
5%
Respiratory Health
5%
CRISPR Technology
5%
Inflammatory Joint Disease
5%
Inhalation
5%
Pulmonary Fibrosis
5%
Host Immune Response
5%
Chronic Obstructive Pulmonary Disease
5%
Bacterial Pneumonia
5%
Inflammatory Lung Disease
5%
Acute Respiratory Distress Syndrome
5%
Trauma
5%
Lung Infection
5%
Neutrophil Biology
5%
Fume
5%
Gene Control
5%
Toxic Materials
5%
Inflammation
5%
Mouse Strain
5%
Stem Cells
5%
Genetic Changes
5%
Multiple Injuries
5%
Illness
5%
Patient Directed
5%
Injury Model
5%
Multiple Diseases
5%
Tissue Damage
5%
Influenza
5%
CRISPR Editing
5%
Direct Therapy
5%
Lung
5%